{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:38Z","timestamp":1740108338647,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008722","name":"University of Girona","doi-asserted-by":"crossref","award":["IFUdG2015\/17","MPCUdG2016\/ref50"],"award-info":[{"award-number":["IFUdG2015\/17","MPCUdG2016\/ref50"]}],"id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00228-019-02742-w","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T11:05:48Z","timestamp":1566385548000},"page":"1659-1667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer\u2019s disease: a cumulative meta-analysis and trial sequential analysis"],"prefix":"10.1007","volume":"75","author":[{"given":"L\u00eddia","family":"Blanco-Silvente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Garre-Olmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Vilalta-Franch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Saez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ant\u00f2nia","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"Capell\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"2742_CR1","volume-title":"Dementia","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) Dementia. WHO, Geneva"},{"key":"2742_CR2","doi-asserted-by":"publisher","unstructured":"Loy C, Schnedier L. Galantamine for Alzheimer\u2019s disease and mild cognitive impairment (Review). Cochrane Database Syst Rev Issue 1. Art. No.: CD001747. \nhttps:\/\/doi.org\/10.1002\/14651858.CD001747.pub3","DOI":"10.1002\/14651858.CD001747.pub3"},{"key":"2742_CR3","doi-asserted-by":"publisher","unstructured":"McShane R, Westby MJ, Roberts E, Minakaran N, Scheider L, Farrimond LE, Maayan N, Ware J, Debarros J. Memantine for dementia (Review). Cochrane Database Syst Rev Issue 3. Art. No.: CD003154. \nhttps:\/\/doi.org\/10.1002\/14651858.CD003154.pub6","DOI":"10.1002\/14651858.CD003154.pub6"},{"key":"2742_CR4","doi-asserted-by":"publisher","unstructured":"Birks JS, Harvey RJ (2018) Donepezil for people with dementia due to Alzheimer\u2019s disease (review). Cochrane Database Syst Rev 6. Art. No.: CD001190. \nhttps:\/\/doi.org\/10.1002\/14651858.CD001190.pub3","DOI":"10.1002\/14651858.CD001190.pub3"},{"key":"2742_CR5","doi-asserted-by":"publisher","unstructured":"Birks JS, Chong L, Grimely Evans J (2015) Rivastigmine for people with Alzheimer\u2019s disease (Review). Cochrane Database Syst Rev Issue 9. Art. No.: CD001191. \nhttps:\/\/doi.org\/10.1002\/14651858.CD001191.pub4","DOI":"10.1002\/14651858.CD001191.pub4"},{"key":"2742_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(13)62297-7","volume":"383","author":"R Al-Shahi Salman","year":"2014","unstructured":"Al-Shahi Salman R, Beller E, Kagan J, Hemminki E, Phillips RS, Macleod M, Wisely J, Chalmers (2014) Increasing value and reducing waste in biomedical research regulation and management. Lancet 383:176\u2013185. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)62297-7","journal-title":"Lancet"},{"key":"2742_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(13)62229-1","volume":"383","author":"I Chalmers","year":"2014","unstructured":"Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, G\u00fclmezoglu AM, Howells DW, Ioannidis JP, Oliver S (2014) How to increase value and reduce waste when research priorities are set. Lancet 383:156\u2013165. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)62229-1","journal-title":"Lancet"},{"key":"2742_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","volume":"383","author":"JP Ioannidis","year":"2014","unstructured":"Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R (2014) Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383:166\u2013175. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)62227-8","journal-title":"Lancet"},{"key":"2742_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12916-015-0492-3","volume":"13","author":"A Dechartres","year":"2015","unstructured":"Dechartres A, Ravaud P (2015) Better priorization to increase research value and decrease waste. BMC Med 13:244. \nhttps:\/\/doi.org\/10.1186\/s12916-015-0492-3","journal-title":"BMC Med"},{"key":"2742_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jclinepi.2016.11.003","volume":"82","author":"Stroz-Pfenning","year":"2017","unstructured":"Stroz-Pfenning (2017) Potentially unnecessary and wasteful clinical trial research detected in cumulative meta-epidemiological and trial sequential analysis. J Clin Epidemiol 82:61\u201370. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2016.11.003","journal-title":"J Clin Epidemiol"},{"key":"2742_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64\u201375. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.013","journal-title":"J Clin Epidemiol"},{"key":"2742_CR12","volume-title":"User manual for trial sequential analysis (TSA)","author":"K Thorlund","year":"2011","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C (2011) User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Copenhagen"},{"key":"2742_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/bmj.39398.682500.25","volume":"335","author":"A Asfhari","year":"2007","unstructured":"Asfhari A, Wetterslev J, Brok J, M\u00f8ller A (2007) Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ 335:1248\u20131251. \nhttps:\/\/doi.org\/10.1136\/bmj.39398.682500.25","journal-title":"BMJ"},{"key":"2742_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00134-015-3899-6","volume":"41","author":"M Volbeda","year":"2015","unstructured":"Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van der Horst IC, Keus F (2015) Glucocorticoids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:1220\u20131234. \nhttps:\/\/doi.org\/10.1007\/s00134-015-3899-6","journal-title":"Intensive Care Med"},{"key":"2742_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1371\/journal.pone.0193924","volume":"8","author":"NJ Sethi","year":"2018","unstructured":"Sethi NJ, Neielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC (2018) Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. PLoS One 8:13:e0193924. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0193924","journal-title":"PLoS One"},{"key":"2742_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12888-016-1173-2","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-M\u00f8ller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C (2017) Selective serotonina reuptake inhibidors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and trial sequential analysis. BMC Psychiatry 17:58. \nhttps:\/\/doi.org\/10.1186\/s12888-016-1173-2","journal-title":"BMC Psychiatry"},{"key":"2742_CR17","doi-asserted-by":"publisher","first-page":"g4561","DOI":"10.1136\/bmj.g4561","volume":"349","author":"A Patel","year":"2014","unstructured":"Patel A, Laffan MA, Waheed U, Vrett SJ (2014) Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ 349:g4561. \nhttps:\/\/doi.org\/10.1136\/bmj.g4561","journal-title":"BMJ"},{"key":"2742_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","volume":"20","author":"L Blanco-Silvente","year":"2017","unstructured":"Blanco-Silvente L, Castells X, Saez M, Barcel\u00f3 MA, Garre-Olmo J, Vilalta-Franch J, Capell\u00e0 D (2017) Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer\u2019s disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16106 patients. Int J Neuropsychopharmacol 20:519\u2013528. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyx012","journal-title":"Int J Neuropsychopharmacol"},{"key":"2742_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12877-018-0857-5","volume":"18","author":"L Blanco-Silvente","year":"2018","unstructured":"Blanco-Silvente L, Capell\u00e0 D, Garre-Olmo J, Vilalta-Franch J, Castells X (2018) Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer\u2019s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients. BMC Geriatr 18:168. \nhttps:\/\/doi.org\/10.1186\/s12877-018-0857-5","journal-title":"BMC Geriatr"},{"key":"2742_CR20","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Green S (2011) The Cochrane Collaboration tool for assessing risk of bias. In: JPT H, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, Copenhagen"},{"key":"2742_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"2742_CR22","volume-title":"Comprehensive meta-analysis version 627 3.3.070","author":"M Borenstein","year":"2014","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H (2014) Comprehensive meta-analysis version 627 3.3.070. Biostat, Englewood"},{"key":"2742_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0140-6736(97)08461-4","volume":"351","author":"J Pogue","year":"1998","unstructured":"Pogue J, Yusuf S (1998) Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351:47\u201352. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(97)08461-4","journal-title":"Lancet"},{"key":"2742_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jclinepi.2008.08.010","volume":"62","author":"GF Borm","year":"2009","unstructured":"Borm GF, Donders AR (2009) Updating meta-analyses leads to larger type I errors than publication bias. J Clin Epidemiol 62:825\u2013830. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2008.08.010","journal-title":"J Clin Epidemiol"},{"key":"2742_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2009","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C (2009) Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol 38:287\u2013298. \nhttps:\/\/doi.org\/10.1093\/ije\/dyn188","journal-title":"Int J Epidemiol"},{"key":"2742_CR26","volume-title":"Trial sequential analysis (TSA) software","author":"K Thorlund","year":"2011","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C (2011) Trial sequential analysis (TSA) software. Copenhagen Trial Unit, Copenhagen"},{"key":"2742_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","volume":"18","author":"J Pogue","year":"1997","unstructured":"Pogue J, Yusuf S (1997) Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 18:580\u2013593. \nhttps:\/\/doi.org\/10.1016\/S0197-2456(97)00051-2","journal-title":"Control Clin Trials"},{"key":"2742_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","volume":"38","author":"K Thorlund","year":"2009","unstructured":"Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, Gluud LL, Als-Nielsen B, Gluud C (2009) Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol 38:276\u2013286. \nhttps:\/\/doi.org\/10.1093\/ije\/dyn179","journal-title":"Int J Epidemiol"},{"key":"2742_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J (2008) Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 61:763\u2013769. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2007.10.007","journal-title":"J Clin Epidemiol"},{"key":"2742_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1532-5415.2008.02122.x","volume":"57","author":"FJ Molnar","year":"2009","unstructured":"Molnar FJ, Man-Son-Hing M, Fergusson D (2009) Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc 57:536\u2013546. \nhttps:\/\/doi.org\/10.1111\/j.1532-5415.2008.02122.x","journal-title":"J Am Geriatr Soc"},{"key":"2742_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046\u20131055. \nhttps:\/\/doi.org\/10.1016\/S0895-4356(01)00377-8","journal-title":"J Clin Epidemiol"},{"key":"2742_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"2742_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. \nhttps:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"2742_CR34","unstructured":"Prescrire (2018) M\u00e9dicaments de la maladie d'Alzheimer: enfin non remboursables en France! \nPrescrire.org\n\n. \nhttp:\/\/www.prescrire.org\/fr\/3\/31\/55116\/0\/NewsDetails.aspx\n\n. Accessed 3 December 2018"},{"issue":"3","key":"2742_CR35","doi-asserted-by":"publisher","first-page":"e000917","DOI":"10.1136\/bmjopen-2012-000917","volume":"2","author":"LE Farrimond","year":"2012","unstructured":"Farrimond LE, Roberts E, McShane R (2012) Memantine and cholinesterase inhibitor combination therapy for Alzheimer\u2019s disease: a systematic review. BMJ Open 2(3):e000917. \nhttps:\/\/doi.org\/10.1136\/bmjopen-2012-000917","journal-title":"BMJ Open"},{"key":"2742_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cct.2015.05.005","volume":"43","author":"J Moncrieff","year":"2015","unstructured":"Moncrieff J, Kirsch I (2015) Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemp Clin Trials 43:60\u201362. \nhttps:\/\/doi.org\/10.1016\/j.cct.2015.05.005","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"2742_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","volume":"88","author":"JT Farrar","year":"2000","unstructured":"Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL (2000) Defining the clinically important difference in pain outcome measures. Pain 88(3):287\u2013294. \nhttps:\/\/doi.org\/10.1016\/S0304-3959(00)00339-0","journal-title":"Pain"},{"key":"2742_CR38","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199411173312007","volume":"331","author":"DA Kessler","year":"1994","unstructured":"Kessler DA, Rose JL, Temple RJ, Schapiro R, Griffin JP (1994) Therapeutic-class wars- drug promotion in a competitive marketplace. N Engl J Med 331:1350\u20131353. \nhttps:\/\/doi.org\/10.1056\/NEJM199411173312007","journal-title":"N Engl J Med"},{"key":"2742_CR39","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/S0140-6736(00)02351-5","volume":"355","author":"D Tallon","year":"2000","unstructured":"Tallon D, Chard J, Dieppe P (2000) Relation between agendas of the research community and the research consumer. Lancet 355:2037\u20132040. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(00)02351-5","journal-title":"Lancet"},{"key":"2742_CR40","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1001\/jama.295.23.2787","volume":"295","author":"BM Psaty","year":"2006","unstructured":"Psaty BM, Rennie D (2006) Clinical trial investigators and their prescribing patterns: another dimesion to the relationship between physician investigators and the pharmaceutical industry. JAMMA 295:2787\u20132790. \nhttps:\/\/doi.org\/10.1001\/jama.295.23.2787","journal-title":"JAMMA"},{"key":"2742_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/0003-4819-149-4-200808190-00012","volume":"149","author":"HC Sox","year":"2008","unstructured":"Sox HC, Rennie D (2008) Seeding trials: just say \u201cno\u201d. Ann Intern Med 149:279\u2013280. \nhttps:\/\/doi.org\/10.7326\/0003-4819-149-4-200808190-00012","journal-title":"Ann Intern Med"},{"key":"2742_CR42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jama.299.8.953","volume":"299","author":"P Greenland","year":"2008","unstructured":"Greenland P, Lloyd-Jones D (2008) Critical lessons from the ENHANCE trial. JAMA 299:953\u2013955. \nhttps:\/\/doi.org\/10.1001\/jama.299.8.953","journal-title":"JAMA"},{"key":"2742_CR43","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1532-5415.2008.01844.x","volume":"56","author":"JR Gilstad","year":"2008","unstructured":"Gilstad JR, Finucane TE (2008) Results, rhetoric, and randomized trials: the case of donepezil. J Am Geriatr Soc 56:1556\u20131562. \nhttps:\/\/doi.org\/10.1111\/j.1532-5415.2008.01844.x","journal-title":"J Am Geriatr Soc"},{"key":"2742_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124500","volume":"10","author":"A Leinonen","year":"2015","unstructured":"Leinonen A, Koponen M, Hartikainen S (2015) Systematic review: representativeness of participants in RCTs of acetylcholinesterase inhibitors. PLoS One 10:e0124500. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0124500","journal-title":"PLoS One"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02742-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T23:07:51Z","timestamp":1597878471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02742-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2742"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02742-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}